Ignite Creation Date:
2025-12-24 @ 1:01 PM
Ignite Modification Date:
2026-02-03 @ 9:12 PM
Study NCT ID:
NCT01934361
Status:
COMPLETED
Last Update Posted:
2020-12-09
First Post:
2013-08-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase Ib/II Study of Buparlisib Plus Carboplatin or Lomustine in Patients With Recurrent Glioblastoma Multiforme
Sponsor:
Novartis Pharmaceuticals
Organization: